Watch ASTH. Know when insiders buy.
One email the day a filing lands. Free.
ASTH
Astrana Health, Inc.
38.47
+0.64 +1.69%
USD · close Sep 4
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
22
FLAG · shorts 22
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.1BP/E 46.3DIV YIELD —FCF YIELD 4.40%REV TTM $3.8B +58.9%NET INCOME $40.5M +60.5%NET CASH $174.7M52W 18.16 – 49.81SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $972.5M | +48.5% | — | $34.3M | $19.7M | +109.5% | 0.40 | $32.7M | $3.9M | $28.9M | Aug 10 |
| Q1 2026 · Mar 31 | $965.1M | +55.6% | — | $28.5M | $14.4M | +115.7% | 0.29 | $68.1M | $4M | $64.1M | May 8 |
| Q4 2025 · Dec 31derived | $950.5M | +42.9% | — | $18.4M | $6M | — | 0.13 | −$2.9M | $3.1M | −$6M | Mar 12 |
| Q3 2025 · Sep 30 | $956M | +99.7% | — | $19.2M | $373K | −97.7% | 0.01 | $10M | $2.6M | $7.4M | Nov 10 |
| Q2 2025 · Jun 30 | $654.8M | +34.7% | — | $20.3M | $9.4M | −50.8% | 0.19 | $90.9M | $1.4M | $89.5M | Aug 10 |
| Q1 2025 · Mar 31 | $620.4M | +53.4% | — | $20.6M | $6.7M | −54.9% | 0.14 | $16.6M | $3.1M | $13.6M | May 8 |
| Q4 2024 · Dec 31derived | $665.2M | +88.4% | — | $720K | −$7M | −156.3% | -0.14 | −$10.9M | $2.5M | −$13.5M | Mar 12 |
| Q3 2024 · Sep 30 | $478.7M | +37.5% | — | $28.4M | $16.1M | −27.0% | 0.33 | $34M | $2.3M | $31.7M | Nov 10 |
| Q2 2024 · Jun 30 | $486.3M | — | — | $30.1M | $19.2M | — | 0.40 | $23.2M | $2.8M | $20.4M | Aug 7 |
| Q1 2024 · Mar 31 | $404.4M | — | — | $30.1M | $14.8M | — | 0.31 | $6M | $369K | $5.6M | May 9 |
| Q4 2023 · Dec 31derived | $353M | — | — | −$3.9M | $12.4M | — | 0.26 | $19.3M | $7.1M | $12.2M | Mar 12 |
| Q3 2023 · Sep 30 | $348.2M | — | — | $39.1M | $22.1M | — | 0.47 | $15.4M | $4.1M | $11.3M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $3.2B | — | $78.5M | $22.5M | 0.7% | 0.46 | $114.6M | $10.1M | $104.5M | $25.6M | $7.9M |
| FY2024 · to Dec 31 | $2B | — | $89.3M | $43.1M | 2.1% | 0.90 | $52.2M | $8M | $44.2M | $900K | $4M |
| FY2023 · to Dec 31 | $1.4B | — | $84.6M | $60.7M | 4.4% | 1.29 | $68.2M | $28.5M | $39.7M | $10.2M | $62.1M |
| FY2022 · to Dec 31 | $1.1B | — | $104.3M | $45.2M | 3.9% | 0.99 | $82.1M | $22.9M | $59.2M | $9.3M | $14M |
| FY2021 · to Dec 31 | $773.9M | 23.0% | $98.2M | $68.9M | 8.9% | 1.52 | $70.3M | $19.2M | $51.1M | $5.7M | $31.1M |
| FY2020 · to Dec 31 | $687.2M | 21.5% | $80.5M | $37.7M | 5.5% | 1.01 | $46.2M | $1.2M | $45M | $537K | $51.3M |
Every number comes from Astrana Health, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.